Skip to main content
. 2016 Sep 5;34(6):750–759. doi: 10.1007/s10637-016-0381-4

Table 4.

Pharmacokinetic parameters of NK105

Dose Cmax Tmax AUC0-inf t1/2 CLtot Vss MRT0-inf
(mg/m2) n (μg/mL) (h) (μg• h/mL) (h) (mL/h/m2) (mL/m2) (h)
50 3 14.2 0.69 176 8.84 286 3140 11.0
± 2.0 ± 0.27 ± 17 ± 3.26 ± 27 ±160 ± 0.6
65 3 18.3 0.71 231 10.3 283 3070 10.8
± 1.3 ± 0.25 ± 18 ± 2.7 ± 22 ± 360 ± 0.5
80 3 22.0 0.80 302 12.7 284 3080 11.2
± 3.3 ± 0.30 ± 104 ± 0.8 ± 82 ± 590 ± 2.0
100 6 27.6 0.80 390 12.3 262 3150 12.0
± 5.3 ± 0.30 ± 64 ± 1.3 ± 39 ± 580 ± 0.9